BioLife Sciences Inc. (BLFE)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | 100.0% |
| 2020 | -984.54 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2007 | 1.56 Million USD | 38.7% |
| 2006 | 1.12 Million USD | 19059.58% |
| 2005 | 5893.00 USD | 0.0% |
| 2004 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2022 Q1 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | 100.0% |
| 2021 Q2 | - USD | 0.0% |
| 2021 Q1 | - USD | 0.0% |
| 2021 Q3 | - USD | 0.0% |
| 2020 FY | -984.54 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2008 Q2 | 356.16 Thousand USD | 204.75% |
| 2008 Q1 | 116.87 Thousand USD | -70.22% |
| 2007 Q2 | 522.14 Thousand USD | 71.89% |
| 2007 Q4 | 392.41 Thousand USD | 12.85% |
| 2007 Q1 | 303.76 Thousand USD | 112.38% |
| 2007 FY | 1.56 Million USD | 38.7% |
| 2007 Q3 | 347.72 Thousand USD | -33.4% |
| 2006 Q2 | 1.12 Million USD | 63.47% |
| 2006 FY | 1.12 Million USD | 19059.58% |
| 2006 Q4 | 143.02 Thousand USD | -79.6% |
| 2006 Q1 | 687.93 Thousand USD | 0.0% |
| 2006 Q3 | 701.08 Thousand USD | -37.66% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 FY | 5893.00 USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Medical Technologies Inc. | 1.69 Million USD | 100.0% |
| Ansell Limited | 624.8 Million USD | 100.0% |
| Ansell Limited | 624.8 Million USD | 100.0% |
| BG Medicine, Inc. | - USD | NaN% |
| Biotage AB (publ) | 113.94 Million USD | 100.0% |
| CB Scientific, Inc. | 135.05 Thousand USD | 100.0% |
| Psykey, Inc. | 415.97 Thousand USD | 100.0% |
| ConvaTec Group Plc | 1.2 Billion USD | 100.0% |
| ConvaTec Group Plc | 1.17 Billion USD | 100.0% |
| Encision Inc. | 3.13 Million USD | 100.0% |
| Golden Valley Development, Inc | - USD | NaN% |
| Hear AtLast Holdings, Inc. | - USD | NaN% |
| Innovative MedTech Inc. | 794.01 Thousand USD | 100.0% |
| LifePoint, Inc. | -71.35 Thousand USD | 100.0% |
| Medite Cancer Diagnostics, Inc. | -131 Thousand USD | 100.0% |
| Paradigm Medical Industries, Inc. | 525 Thousand USD | 100.0% |
| QuantRx Biomedical Corporation | - USD | NaN% |
| Remedent, Inc. | 603.24 Thousand USD | 100.0% |
| Reflect Scientific, Inc. | 596.42 Thousand USD | 100.0% |
| SmileDirectClub, Inc. | 275.84 Million USD | 100.0% |
| Sector 10, Inc. | - USD | NaN% |
| Shandong Weigao Group Medical Polymer Company Limited | 900.72 Million USD | 100.0% |
| SheerVision, Inc. | 2.17 Million USD | 100.0% |
| United Health Products, Inc. | -4857.00 USD | 100.0% |
| Vasamed, Inc. | -69.38 Thousand USD | 100.0% |
| Wearable Health Solutions, Inc. | 267.66 Thousand USD | 100.0% |
| Yubo International Biotech Limited | 52.65 Thousand USD | 100.0% |